Not Signed In -
Prostate |
|
|
Male Anatomy The prostate is an exocrine gland of the male mammalian reproductive system. Its main function is to store and secrete a clear, slightly basic fluid that constitutes up to one-third of the volume of semen. The prostate differs considerably between species anatomically, chemically, and physiologically. A healthy human prostate is slightly larger than a walnut. It surrounds the urethra just below the urinary bladder. It is located in front of the rectum and can be felt durin ...
Wikipedia - [full article]
Prostate Clinical Trials
- Positioning and Tracking the Prostate During External Beam Radiation
ClinicalTrials.gov Identifier: NCT00123838 - Active, not recruiting
Prostate Cancer; Cancer of Prostate; Neoplasms, Prostate
- Diet and PSA Levels in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005960 - Active, not recruiting
stage II prostate cancer; Pain; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003084 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- PET Scan in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005947 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004928 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00020995 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002723 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00077402 - Active, not recruiting
recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003400 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- 17-AAG in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
ClinicalTrials.gov Identifier: NCT00118092 - Active, not recruiting
recurrent prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer
- Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00019695 - Active, not recruiting
Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002760 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- A Study of Docetaxel Plus Carboplatin in Patients with Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00134706 - Active, not recruiting
Prostate Cancer; Cancer of the Prostate; Cancer of Prostate
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00084526 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003903 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; Osteoporosis
- Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate
ClinicalTrials.gov Identifier: NCT00030290 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer
- GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
Prostate Cancer
- Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
ClinicalTrials.gov Identifier: NCT00003858 - Active, not recruiting
stage III prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer; stage I prostate cancer
- Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00054509 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
ClinicalTrials.gov Identifier: NCT00080899 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer
- PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003871 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00085228 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
ClinicalTrials.gov Identifier: NCT00045123 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030277 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- NCI HIGH PRIORITY CLINICAL TRIAL --- Prostatectomy Compared With Watchful Waiting in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002606 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
- ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)
ClinicalTrials.gov Identifier: NCT00090363 - Active, not recruiting
Prostate Cancer
- Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
ClinicalTrials.gov Identifier: NCT00004026 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082680 - Active, not recruiting
recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003533 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002602 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00052845 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003516 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002511 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00071968 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
- Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00039104 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
ClinicalTrials.gov Identifier: NCT00046826 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00024414 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003183 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016107 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003534 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00027781 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00027794 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
ClinicalTrials.gov Identifier: NCT00078923 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
- Lycopene in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00068731 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002703 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
- Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082693 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00003622 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00017563 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00003391 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Atrasentan in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00046943 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005992 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028574 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer; Hot Flashes
- Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003232 - Active, not recruiting
Pain; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00031889 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy
ClinicalTrials.gov Identifier: NCT00126815 - Active, not recruiting
Prostate Cancer
- Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00043069 - Active, not recruiting
Osteoporosis; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
ClinicalTrials.gov Identifier: NCT00005073 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer; Quality of Life
- Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004043 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006023 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
ClinicalTrials.gov Identifier: NCT00181558 - Active, not recruiting
Prostate Cancer; Adenocarcinoma of the Prostate
- Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00182052 - Active, not recruiting
Adenocarcinoma of the Prostate; Prostate Cancer
- Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00110162 - Recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Prostate Immobilization Device used during Radiation Treatments to Decrease Rectal Bleeding
ClinicalTrials.gov Identifier: NCT00114985 - Active, not recruiting
Prostate Cancer
- Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00087035 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003717 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00122265 - Active, not recruiting
Prostate Cancer
- Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
ClinicalTrials.gov Identifier: NCT00031746 - Active, not recruiting
Prostate Cancer
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Clinical Trial for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
Prostate Cancer
- Cilengitide in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103337 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer
- Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer
Resources
- CancerResource (American Institute for Cancer Research)
- Cáncer de la próstataTratamiento - Pacientes (National Cancer Institute)
email this page
print this page
bookmark this page
feedback on this page
